Publicaciones en las que colabora con NATO APTSIAURI (15)

2016

  1. Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance

    Cancer Immunology, Immunotherapy, Vol. 65, Núm. 1, pp. 47-59

2013

  1. MHC class I antigens in malignant cells: Immune escape and response to immunotherapy

    Springer New York, pp. 1-51

  2. MHC class i antigens and the tumor microenvironment

    The Tumor Immunoenvironment (Springer Netherlands), pp. 253-286

2012

  1. Cancer immune escape: Implications for immunotherapy, Granada, Spain, October 3-5, 2011

    Cancer Immunology, Immunotherapy

2011

  1. Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells

    International Journal of Cancer, Vol. 129, Núm. 4, pp. 839-846

  2. Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors

    Immunogenetics, Vol. 63, Núm. 2, pp. 65-71

2010

  1. "Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy

    International Journal of Cancer

2009

  1. HLA and melanoma: Multiple alterations in HLA class i and II expression in human melanoma cell lines from ESTDAB cell bank

    Cancer Immunology, Immunotherapy, Vol. 58, Núm. 9, pp. 1507-1515

2008

  1. HLA class I expression, tumor escape and cancer progression

    Current Cancer Therapy Reviews, Vol. 4, Núm. 2, pp. 105-110

  2. Regressing and progressing metastatic lesions: Resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

    Cancer Immunology, Immunotherapy

2007

  1. International conference: Progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain

    Cancer Immunology, Immunotherapy

  2. MHC Class I Antigens and Immune Surveillance in Transformed Cells

    International Review of Cytology, Vol. 256, pp. 139-189

  3. Role of altered expression of HLA class i molecules in cancer progression

    Advances in Experimental Medicine and Biology

2006

  1. Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma

    Tissue Antigens, Vol. 68, Núm. 4, pp. 303-310

  2. LOH at 6p21.3 region and HLA class altered phenotypes in bladder carcinomas

    Immunogenetics, Vol. 58, Núm. 7, pp. 503-510